Does POLATUZUMAB VEDOTIN Cause Hepatotoxicity? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatotoxicity have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 0.2% of all adverse event reports for POLATUZUMAB VEDOTIN.
9
Reports of Hepatotoxicity with POLATUZUMAB VEDOTIN
0.2%
of all POLATUZUMAB VEDOTIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hepatotoxicity From POLATUZUMAB VEDOTIN?
Of the 9 reports, 1 (11.1%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Hepatotoxicity Listed in the Official Label?
Yes, Hepatotoxicity is listed as a known adverse reaction in the official FDA drug label for POLATUZUMAB VEDOTIN.
What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?
Disease progression (1,131)
Off label use (692)
Anaemia (344)
Blood lactate dehydrogenase increased (307)
Drug ineffective (305)
Neutropenia (303)
Death (295)
Covid-19 (286)
Febrile neutropenia (286)
Pyrexia (285)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which POLATUZUMAB VEDOTIN Alternatives Have Lower Hepatotoxicity Risk?
POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ
POLATUZUMAB VEDOTIN vs POLIDOCANOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM